Review
doi: 10.1046/j.1537-2995.2002.00200.x.
International application of the incidence rate/window period model
- PMID: 12385404
- DOI: 10.1046/j.1537-2995.2002.00200.x
Item in Clipboard
Review
International application of the incidence rate/window period model
Transfusion.
2002 Aug.
No abstract available
Comment on
-
Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population.Transfusion. 2002 Aug;42(8):975-9. doi: 10.1046/j.1537-2995.2002.00174.x. Transfusion. 2002. PMID: 12385406
-
Trends in residual risk of transfusion-transmitted viral infections in France between 1992 and 2000.Transfusion. 2002 Aug;42(8):980-8. doi: 10.1046/j.1537-2995.2002.00155.x. Transfusion. 2002. PMID: 12385407
-
Residual risk of transfusion-transmitted HCV and HIV infections by antibody-screened blood in Italy.Transfusion. 2002 Aug;42(8):989-93. doi: 10.1046/j.1537-2995.2002.00173.x. Transfusion. 2002. PMID: 12385408
-
Estimated risk of transfusion-transmitted viral infections in Spain.Transfusion. 2002 Aug;42(8):994-8. doi: 10.1046/j.1537-2995.2002.00154.x. Transfusion. 2002. PMID: 12385409
Similar articles
-
Further enhancement of the safety of human plasma derivatives.Transfusion. 2002 Aug;42(8):973-4. doi: 10.1046/j.1537-2995.2002.00199.x. Transfusion. 2002. PMID: 12385405 No abstract available.
-
Transfusion-transmitted viral infections: building bridges to transfusion medicine to reduce risks and understand epidemiology and pathogenesis.Transfusion. 2006 Sep;46(9):1624-40. doi: 10.1111/j.1537-2995.2006.00957.x. Transfusion. 2006. PMID: 16965593 No abstract available.
-
Estimated risk of transfusion-transmitted viral infections in Spain.Transfusion. 2002 Aug;42(8):994-8. doi: 10.1046/j.1537-2995.2002.00154.x. Transfusion. 2002. PMID: 12385409
-
Approaches to the reduction of viral infectivity in cellular blood components and single donor plasma.Transfus Med Rev. 1991 Jan;5(1):18-32. doi: 10.1016/s0887-7963(91)70190-9. Transfus Med Rev. 1991. PMID: 1802274 Review. No abstract available.
-
[Viral safety measures of plasma for transfusion and applicability in Spain].Med Clin (Barc). 2007 Oct 6;129(12):458-68. doi: 10.1157/13111004. Med Clin (Barc). 2007. PMID: 17953912 Review. Spanish. No abstract available.
Cited by
-
Proposed new definition for hospital-acquired SARS-CoV-2 infections: results of a confirmatory factor analysis.Antimicrob Steward Healthc Epidemiol. 2024 Sep 9;4(1):e125. doi: 10.1017/ash.2024.371. eCollection 2024. Antimicrob Steward Healthc Epidemiol. 2024. PMID: 39257431 Free PMC article.
-
The Impact of Critical Care Quarantine on the Residual Risk of Unexpected Organ Donor Blood-borne Virus Infection.Transplant Direct. 2025 Aug 13;11(9):e1843. doi: 10.1097/TXD.0000000000001843. eCollection 2025 Sep. Transplant Direct. 2025. PMID: 40810059 Free PMC article.
-
Emerging infections in transfusion medicine.Clin Lab Med. 2004 Sep;24(3):797-823, viii. doi: 10.1016/j.cll.2004.05.009. Clin Lab Med. 2004. PMID: 15325065 Free PMC article. Review.
-
Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.CMAJ. 2003 Oct 14;169(8):767-73. CMAJ. 2003. PMID: 14557314 Free PMC article.
-
HCV RNA Testing of Plasma Samples from Cornea Donors: Suitability of Plasma Samples Stored at 4 °C for up to 8 Days.Transfus Med Hemother. 2017 Jan;44(1):39-44. doi: 10.1159/000449207. Epub 2016 Nov 4. Transfus Med Hemother. 2017. PMID: 28275332 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
